Weight Loss Drugs arent “the answer”
Sheffield DPH
FEBRUARY 21, 2024
Before you read this, you must read Phil’s New Statesman article on GLP1 agonists. 2% could be higher depending on the population group who end up taking the drug (when you think about other risk factors for gallstones e.g. women, over 40). likely to widen health inequalities. Quite a good article. “At
40 
Let's personalize your content